Breast Cancer Prevention
15
4
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (15)
Active Mammography and Counseling
Rutgers University Study of the Genetics of Breast Cancer.
PR-CEAL: Community Outreach Engagement Group
MELIORA Virtual Coach Intervention for Breast Cancer Prevention
MELIORA Data Collection Campaigns
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
Adherence to the Mediterranean Diet Among Women Attending Mammographic Screening
Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?
Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome
A Randomized Controlled Trial to Increase Breast Cancer Screening Uptake
RANKL Inhibition and Breast Tissue Biomarkers
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk
Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development
Breast Cancer Prevention Education
Effect of Exercise on Sex Hormones in Postmenopausal Women